Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Luzhou People’s Hospital | China

Dr. Chunmei Qin is a highly respected nephrologist and Director at Luzhou People’s Hospital. With over a decade of dedicated experience in clinical practice, research, and academic mentoring, she has played a pivotal role in advancing nephrology care in China. Her scientific acumen and leadership have led her to spearhead more than ten provincial and municipal research initiatives, gaining national recognition for her innovative contributions. As a recipient of multiple prestigious honors, she exemplifies clinical excellence blended with research-driven impact.

Author Profile👤

Scopus

Strengths for the Awards✨

Dr. Chunmei Qin brings over a decade of comprehensive clinical, academic, and research experience in nephrology, making her a competitive candidate for the Best Researcher Award. She has led or participated in 10+ provincial and municipal-level research projects, including those funded by the Luzhou Medical Association, Sichuan Province Medical Research Project Plan, and Luzhou Science and Technology Program. Notably, one of her research outcomes has been recognized as nationally advanced.

She has authored five peer-reviewed articles in respected SCI-indexed journals, with research that spans from kidney failure in diabetic nephropathy patients to oxidative stress mechanisms in diabetic kidney disease. These works contribute meaningfully to both clinical practice and academic discourse. Additionally, she has received multiple accolades, including:

  • Outstanding Young Paper Award by the Sichuan Medical Association.

  • Outstanding Contribution Award by the Municipal Health Commission.

Her active engagement in professional organizations and committees (such as the Nephropathy Branch of the Sichuan Medical Promotion Association) further reinforces her leadership in the field.

🎓 Education

Dr. Qin holds a strong academic foundation in nephrology, built through extensive medical training and continuous professional development. Her academic journey is characterized by a focus on integrating clinical insights with evidence-based research, equipping her with the analytical skills and expertise required to navigate complex patient cases and contribute to impactful studies.

🏥 Experience

Currently serving as Director at Luzhou People’s Hospital, Dr. Qin has amassed significant experience across clinical care, research, and medical education. Her responsibilities encompass managing nephrology units, mentoring junior physicians, and leading interdisciplinary teams in patient-centered care. Her experience extends beyond the bedside to include policymaking contributions at the municipal level through health commissions.

🔬 Research Interests On Medicine and Health Sciences

Dr. Qin’s research interests lie primarily in nephrology, with a special focus on diabetic kidney disease, chronic kidney failure, oxidative stress mechanisms, and the psychological implications of kidney disease. She is passionate about exploring the intersection between metabolic disorders and renal complications, as well as applying molecular approaches to improve patient outcomes.

🏆 Awards

Dr. Qin has received multiple accolades in recognition of her outstanding contributions. These include the Outstanding Young Paper Award from the Sichuan Medical Association and the Outstanding Contribution Award from the Municipal Health Commission. Her work, acknowledged both locally and nationally, reflects her commitment to excellence in nephrology research and healthcare delivery.

📄 Publications

Dr. Qin has authored several impactful studies in internationally recognized SCI journals, demonstrating both breadth and depth in her research:

  1. Qin, C., Wu, Y., Zou, Y., et al. Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy, BMC Nephrology, 2025; 26:54. Cited by multiple nephrology scholars for its clinical relevance.

  2. Qin, C., Wang, Y., Zhao, L., et al. Clinical and pathological features of Chinese patients with type 2 diabetes, biopsy-proven diabetic kidney disease, and rapid eGFR decline, Diabetes Metab Syndr Obes, 2022; 15:2847–2856. Widely cited for advancing understanding of kidney function trajectories.

  3. Qin, C., Yin, D., Liu, F., et al. Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy: a case report, BMC Nephrology, 2023; 24(1):143. Referenced in case studies on rare renal pathologies.

  4. Zhang, R., Qin, C., Zhang, J., et al. DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc pathway in diabetic kidney disease, FASEB Journal, 2024; 38(6):e23564. Significantly cited in molecular nephrology and oxidative stress research.

  5. Qin, C., Li, G., Yuan, Y., et al. Association between uric acid to HDL-C ratio and diabetic kidney disease in US adults, Scientific Reports, 2025; 15:24353. Cited for its epidemiological insights on metabolic markers.

Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Minya University | Egypt

Dr. Marwa Monier Mahmoud Refaie is an esteemed Egyptian pharmacologist and academician currently serving as an Assistant Professor in the Department of Pharmacology, Faculty of Medicine, Minia University. With an H-index of 18 on both Scopus and Google Scholar, she has made impactful contributions to pharmacological research, particularly in drug safety, toxicology, and disease treatment models. Born on July 2, 1983, in Mallawi, El-Minia, Dr. Refaie balances her thriving career with family life, being a proud mother of three sons.

Professional profile👤

Google Scholar

Scopus

ORCID

Strengths for the Awards✨

Dr. Marwa Monier Mahmoud Refaie demonstrates a remarkable profile that aligns seamlessly with the ethos of the Pioneer Researcher Award. With over 16 years of academic and research experience in pharmacology, she has established herself as a thought leader in experimental and clinical pharmacology, especially in toxicology, nephroprotection, cardioprotection, and hormonal therapy research.

Her impressive H-index of 18 (Scopus & Google Scholar) reflects the consistent impact of her work on the scientific community. Dr. Refaie has authored over 40 international publications, many in high-impact journals, and has investigated novel therapeutic mechanisms for critical conditions like nephrotoxicity, PCOS, and ischemia-reperfusion injuries. Her robust experimental skill set, prolific mentorship of postgraduate students, and service on editorial boards of globally recognized journals (e.g., British Journal of Pharmacology, Elsevier journals) reflect both leadership and innovation in her field. Moreover, her multiple awards from Minia University for international publication over consecutive years affirm her consistency and excellence in pioneering pharmacological research.

🎓 Education

Dr. Refaie began her academic journey at Minia University, earning her MBBS in Medicine and Surgery in 2006. She further specialized in pharmacology, completing her Master’s in 2011 and a Ph.D. in Basic and Clinical Pharmacology in 2016. Expanding her interdisciplinary expertise, she also earned a Diploma in Infection Control in 2021, highlighting her dedication to integrated healthcare education and safety.

🧪 Experience

With over 16 years of academic and research experience, Dr. Refaie has evolved from a Demonstrator to Assistant Professor at Minia University. Her work spans teaching basic and clinical pharmacology to medical, dental, pharmacy, and nursing students, and supervising numerous M.Sc. and Ph.D. theses. Her research explores pharmacotherapy, cancer, autoimmune diseases, and drug safety, and she has actively contributed to institutional accreditation, infection control, and community healthcare education.

🔬 Research Interests On Medicine and Health Sciences

Dr. Refaie’s research is driven by a passion for understanding and combating toxicological and precancerous conditions. Her focus lies in modeling and treating organ-specific toxicity, ischemia-reperfusion injuries, and hyperplastic lesions. Her work also explores novel mechanisms of cardioprotection, reproductive toxicity, and immunomodulation using pharmacological agents such as diacerein, fenofibrate, and SGLT2 inhibitors.

🏆 Awards

Dr. Refaie has received consistent recognition for her excellence in research and publication. She was awarded first place at the 57th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics (2018). Additionally, she has received Minia University’s International Publication Award for six consecutive years (2019–2024), reflecting her sustained contributions to global pharmacological science.

📚 Publications

  • Effect of coenzyme‐Q10 on doxorubicin‐induced nephrotoxicity in rats
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai, AM Abdelrahman
    2012 – Cited by: 147

  • Possible protective effect of diacerein on doxorubicin‐induced nephrotoxicity in rats
    MMM Refaie, EF Amin, NF El-Tahawy, AM Abdelrahman
    2016 – Cited by: 96

  • Mechanism mediating the protective effect of diacerein in ischemia-reperfusion-induced testicular injury in rats
    SA Abdel-Gaber, RK Mohammed, MMM Refaie
    2018 – Cited by: 62

  • Protective mechanisms of coenzyme-Q10 may involve up-regulation of testicular P-glycoprotein in doxorubicin-induced toxicity
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai
    2014 – Cited by: 52

  • Naringenin palliates cisplatin and doxorubicin gonadal toxicity in male rats
    AA Fouad, MMM Refaie, MI Abdelghany
    2019 – Cited by: 50

  • The role of interleukin‐1β and its antagonist (diacerein) in estradiol benzoate‐induced endometrial hyperplasia and atypia in female rats
    MMM Refaie, M El‐Hussieny
    2017 – Cited by: 48

  • Role of ATP-Sensitive Potassium Channel (KATP) and eNOS in Mediating the Protective Effect of Nicorandil in Cyclophosphamide-Induced Cardiotoxicity
    MMM Refaie, S Shehata, M El-Hussieny, WM Abdelraheem, …
    2020 – Cited by: 46

  • Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
    WM Abdelraheem, MMM Refaie, RKM Yousef, AS Abd El Fatah, …
    2022 – Cited by: 44

  • Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways
    MMM Refaie, M El-Hussieny, NM Zenhom
    2018 – Cited by: 43

  • Protective effect of pioglitazone on ovarian ischemia reperfusion injury of female rats via modulation of peroxisome proliferator activated receptor gamma and heme-oxygenase 1
    MMM Refaie, M El-Hussieny
    2018 – Cited by: 41

📝 Conclusion

🌟 Dr. Marwa M. Refaie exemplifies excellence in academic pharmacology through her sustained research, impactful publications, and commitment to medical education. Her work spans cutting-edge experimental pharmacology, disease modeling, and immunotherapy. Her consistent accolades, active international collaborations, and editorial contributions to top journals affirm her candidacy as a distinguished nominee for prestigious research awards. Her legacy in pharmacological sciences continues to inspire and uplift the global scientific community.